2 Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med. 2020;173:362–7.
3 Kasper M, Geibe J, Sears C, et al. An outbreak of Covid-19 on an aircraft carrier. N Engl J Med. 2020;383:2417–26.
4 Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;3099:669–77.
5 Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782–93.
6 Yang F, Shi S, Zhu J, et al. Analysis of 92 deceased patients with COVID-19. J Med Virol. 2020;92:2511–5.
7 Wei-jie G, Zheng-yi N, Yu H, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–20.
8 Gibson PG, Qin L, Puah SH. COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS. Med J Aust. 2020;213:54–6.
9 Wang Y, Jin C, Wu CC, et al. Organizing pneumonia of COVID-19: Time-dependent evolution and outcome in CT findings. PLoS One. 2020;15(11):e0240347.
10 Liu J, Chen T, Yang H, et al. Clinical and radiological changes of hospitalised patients with COVID-19 pneumonia from disease onset to acute exacerbation: a multicentre paired cohort study. Eur Radiol. 2020;30:5702–8.
11 Berlin D, Gulick R, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;383:2451–60.
12 Satre Buisson L. Coagulopathie associée au COVID-19: les éléments essentiels pour l’anesthésiste-réanimateur. Prat Anesth Reanim. 2020;24:190–5.
13 Grillet F, Behr J, Calame P, et al. Acute pulmonary embolism associated with COVID-19 pneumonia detected with pulmonary CT angiography. Radiology. 2020;296:E186–E188.
14 Franchitti M, Grandjean A, Laurent J-C. AVC ischémique après thrombolyse d’une embolie pulmonaire dans le contexte de COVID-19. Forum Med Suisse. 2021;21:26–8.
15 Stephan D, Cordeanu M, Mirea C, et al. Maladie veineuse thromboembolique et COVID-19. Med Form. 2020;10.1010/j.lpmfor.2020.08.005.
16 Casini A, Fontana P, Glauser F, et al. Risque thrombotique veineux induit par le SARS-CoV-2: prévalence, recommandations et perspectives. Rev Med Suisse. 2020;16:951–4.
17 Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.
18 Zhao W, Zhong Z, Xie X, et al. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. AJR Am J Roentgenol. 2020;214:1072–7.
19 RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR et al. Dexamethasone in hospitalized patients with covid-19 - preliminary report. N Engl J Med. 2020:NEJMoa2021436.
20 Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71:2459–68.
21 Sieswerda E, de Boer MGJ, Bonten MMJ, et al. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline. Clin Microbiol Infect. 2021;27:61–6.
22 Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020;296:E32–E40.
23 Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.
24 Jacobi A, Chung M, Bernheim A, et al. Portable chest X-ray in coronavirus disease-19 (COVID-19): a pictorial review. Clin Imaging. 2020;64:35–42.
25 Muheim M, Weber F, Muggensturm P, et al. An unusual course of disease in two patients with COVID-19: pulmonary cavitation. BMJ Case Rep. 2020;13:e237967.
26 Renaud-Picard B, Gallais F, Riou M, et al. Delayed pulmonary abscess following COVID-19 pneumonia: a case report. Respir Med Res. 2020;78:100776.
27 Zoumot Z, Bonilla M-F, Wahla AS et al. Pulmonary cavitation: an under-recognized late complication of severe COVID-19 lung disease. BMC Pulm Med. 2021;21:24.
28 Clottu E, Nicod L.P. Abcès pulmonaires: évolution dans la prise en charge? Rev Med Suisse. 2015;11:2176–83.
29 McGuinness G, Zhan C, Rosenberg N, et al. Increased incidence of barotrauma in patients with COVID-19 infection on invasive mechanical ventilation. Radiology. 2020;297:E257–E262.
30 Martinelli AW, Ingle T, Newman J, et al. COVID-19 and pneumothorax: a multicentre retrospective case series. Eur Respir J. 2020;56:2002697.
31 Sun R, Liu H, Wang X. Mediastinal emphysema, giant bulla, and pneumothorax developed during the course of COVID-19 pneumonia. Korean J Radiol. 2020;21:541–4.
32 Ferreira JG, Rapparini C, Gomes BM, et al. Pneumothorax as a late complication of COVID-19. Rev Inst Med Trop Sao Paulo. 2020;62:e61.
33 Pieracci FM, Burlew CC, Spain D, et al. Tube thoracostomy during the COVID-19 pandemic: guidance and recommendations from the AAST Acute Care Surgery and Critical Care Committees. Trauma Surg Acute Care Open. 2020;5:e000498.
34 Shan S, Guangming L, Wei L, Xuedong Y. Spontaneous pneumomediastinum, pneumothorax and subcutaneous emphysema in COVID-19: case report and literature review. Rev Inst Med Trop Sao Paulo. 2020;62:e76.
35 Horii H, Kamada K, Nakakubo S, et al. Rapidly progressive organizing pneumonia associated with COVID-19. Respir Med Case Rep. 2020;31:101295.
36 Kory P, Kanne JP. SARS-CoV-2 organising pneumonia: ‘Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?’ BMJ Open Respiratory Research. 2020;7:e000724.
37 Vadász I, Husain-Syed F, Dorfmüller P, et al. Severe organising pneumonia following COVID-19. Thorax. 2021;76:201–4.
38 Lebowitz D, Gex G, Pache JC, et al. La pneumonie organisée cryptogénique. Rev Med Suisse. 2013;9:2164–69.
39 Site de la NHS: https://www.nhs.uk/conditions/coronavirus-covid-19/long-term-effects-of-coronavirus-long-covid/
40 Bellan M, Soddu D, Balbo PE, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. 2021;4:e2036142.
41 Guler SA, Ebner L, Beigelman C, et al. Pulmonary function and radiological features four months after COVID-19: first results from national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021;2003690.
42 Lechowicz K, Drożdżal S, Machaj F, et al. COVID-19: the potential treatment of pulmonary fibrosis associated with SARS-CoV-2 infection. J Clin Med. 2020;9:1917.
43 van Dongen C, Janssen MT, van der Horst RP, et al. Unusually rapid development of pulmonary hypertension and right ventricular failure after COVID-19 pneumonia. Eur J Case Rep Intern Med. 2020;7:001784.
44 ARDS Definition Task Force; Ranieri VM, Rubenfeld GD, Thompson BT. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307:2526–33.